Post-traumatic stress disorder (PTSD) is a debilitating mental disorder precipitated by trauma exposure. However, only some persons exposed to trauma develop PTSD. There are sex differences in risk; twice as many women as men, develop a lifetime diagnosis of PTSD.
INTRODUCTION
Post-traumatic stress disorder (PTSD) is a debilitating mental disorder that is precipitated by a traumatic experience involving direct or indirect exposure to actual or threatened death, serious injury, or sexual violence 1 . PTSD presents with intrusive and persistent re-experiencing of the traumatic event, avoidance of distressing, trauma-associated stimuli, negative alterations in cognition and mood, and alterations in arousal/reactivity that persist for longer than a month 1 .
While most individuals are exposed to a potentially traumatic event at some point in their lives, only some develop PTSD [2] [3] [4] [5] [6] [7] [8] , suggesting that the disorder reflects a distinct inability to reinstate homeostasis after psychological trauma in vulnerable individuals 9 .
Epidemiological studies have identified sex to be a significant vulnerability factor for developing PTSD, with women twice as likely to have lifetime PTSD than men, even when risk of exposure and types of trauma are taken into consideration 3, 4, 8, [10] [11] [12] . This sex bias in disease prevalence is also observed in depression 13 and other commonly occurring mood and anxiety disorders 14 that are heavily influenced by stress exposure. Preclinical and clinical investigations have identified sexual dimorphism in stress response systems that may be involved in the increased prevalence of stress-related psychopathologies in women 15, 16 . Furthermore, in addition to sexual dimorphism in the neurobiological underpinnings of stress/trauma response, recent animal studies suggest that behavioral response to traumatic stress is fundamentally different between males and females and should be considered in interpretation of results 17 . In humans, response to stress/trauma exposure involves both biological and social contributors corresponding to sex and gender-related variables. While the effects of sex and gender are difficult to disentangle, investigations stratified by biological sex, understood to interact with gender-related variables, are warranted to improve our currently limited understanding of the sex-specific biological processes dysregulated in PTSD pathophysiology.
Mounting evidence suggests a key role for stress-induced inflammation and immune alteration in the development and maintenance of PTSD and other stress-related psychiatric disorders. Although findings from human literature have been mixed, PTSD has generally been associated with increased pro-inflammatory tone, basally and in response to immune challenge, via both cytokine signaling and changes in immune cell distribution/function [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] . Investigations in animal models, specifically male rodent studies, have provided mechanistic insights into how peripheral immune cell response/signaling and distribution is linked with microglial activation and neuroinflammatory dynamics to trigger stress-induced anxiety behavior and memory impairment [35] [36] [37] [38] [39] [40] .
Epigenetic mechanisms have emerged as important regulators of PTSD-associated immune dysregulation and inflammation [41] [42] [43] [44] [45] [46] , and are particularly significant for the study of PTSD because they capture the interactions among pre-disposing genetic/environmental risk factors and the precipitating trauma exposure. Individual response to trauma exposure can be encoded as short-lived or persistent epigenetic changes that reflect and may contribute to posttraumatic physiological changes, some of which remain after remission of PTSD symptoms.
DNA methylation (DNAm) has been the most widely studied epigenetic mechanism and evidence from both animal and human models point to its key role in stress regulation 9,47-49 , fear memory [50] [51] [52] [53] [54] , and immune function [43] [44] [45] [46] [55] [56] [57] [58] , in both brain and blood. Exploring PTSD-associated DNAm profiles in blood may inform our understanding of mechanisms underlying immune dysregulation, particularly those that coordinate peripheral immune-neuroimmune crosstalk 59, 60 .
Peripheral blood-based methylomic profiles are comprised of two dynamic components: 1) profiles reflecting proportions of immune cell subtypes (i.e., leukocyte composition) and 2) alterations in DNAm levels at CpG sites genome-wide (i.e., differential methylation).
Epigenome-wide association studies (EWAS) often seek to identify dynamic differential methylation marks and treat cellular heterogeneity as a major confound that must be addressed to improve signal detection. However, shifts in leukocyte subtypes provide key insights into immunological changes and warrant examination themselves. Recent developments in deconvolution algorithms and cell-type discriminating reference databases have improved estimates [61] [62] [63] [64] and enabled utility of DNAm-based leukocyte subtype estimates as proxies for white blood cell differential-based metrics 65, 66 . Leveraging these recently developed methods, here we use leukocyte-derived methylomic profiles combined from two civilian cohorts to investigate our hypothesis that PTSD is associated with sex-specific shifts in leukocyte composition, detectable by DNAm-based estimates. To our knowledge, this study is the first to investigate leukocyte composition profiles in PTSD using these new DNAm-based approaches for immune profiling. 
MATERIALS AND METHODS

Study Participants
Quality control and pre-processing of 450K Data
The raw .idat files were imported into R (version 3.5.1) 83 , using the minfi 84 Bioconductor (version 3.7) 85, 86 package, for all subsequent data processing and analyses. After quality control (QC) 84, 87, 88 , data pre-processing [89] [90] [91] [92] [93] [94] was conducted on all QC'ed samples (DNHS: n = 187; GTP: n = 390). This included duplicates in the DNHS and participants with missing data in the GTP.
Analyses were conducted on unique participants that passed QC, as described below, and had PTSD data available (Table 1) .
For data quality assessment, samples were checked for 1) low total signal (mean signal intensity less than half of the overall median, after setting probes with detection p-value > 0.001 or < 2,000 arbitrary units to missing); 2) > 1% of failed probes (detection p-value > 0.001); 3) outlying beta value distribution (i.e., smaller than three times interquartile range (IQR) from the lower quartile or larger than 3 times IQR from the upper quartile); 4) greater than three standard deviations of the mean bisulfite conversion control probe signal intensity 64 . Additionally, samples were checked for gender discordance based on median total intensity of X and Ychromosome mapped probes (as implemented in minfi 84 ) and removed if predicted sex differed from self-reported gender. Five samples were removed among DNHS samples for gender discordance, and six samples were removed among GTP samples (two for data quality and four for gender discordance). After within-array background correction and dye-bias equalization using out-of-band control probes (ssNoob 90, 95 ; minfi), probes with detection p-value > 0.001 in more than 10% of samples 87 and cross-reactive probes 91 (i.e., cross-hybridized between autosomes and sex chromosomes) were removed. Beta-mixture quantile (BMIQ) normalization (ChAMP 93, 94 ) was used to correct for type II probe bias 92 .
To control for technical artifacts (e.g., sample processing and imaging batch effects), PCs based on non-negative control probe signal intensity 88 were removed from BMIQ-normalized Mvalues (i.e., logit-transformed beta-values) separately for each study. PC correlation heatmaps were used to check for successful removal/reduction of batch effects, especially chip and row effects, while maintaining signal from biological variables. The DNHS and GTP datasets were then combined and an empirical Bayes method (i.e., ComBat 96 in the sva package 97 ) was used on the combined M-values to account for study effects while controlling for sex and age. Data quality assessment, QC probe filtering, and first step of batch removal were study-specific, while pre-processing steps (ssNoob+BMIQ) implemented within-array approaches unaffected by study. Only probes that passed QC in both studies (n = 455,072 probes) were included in the combined dataset.
Leukocyte Composition Estimation
Leukocyte composition was estimated on ComBat-adjusted beta-values using the (2012) 99 , was used to calculate a second set of estimates for comparison.
Ancestry Estimation
DNAm-based ancestry principal components (PCs) were derived on cleaned beta-values after regressing out sex and age from batch-adjusted M-values. Ancestry PCs were calculated on a subset of 2,317 ancestry informative CpG probes included in two published ancestry informative CpG lists that accounted for confounders 100 and that included probes within 10 base pairs (bp) of single nucleotide polymorphisms (SNPs) 101 . The first 2 PCs based on this subset of probes were used as ancestry PCs (ancPCs) after checking for strong association with selfreported race and effective separation of self-reported races.
Statistical Analysis
The Shapiro-Wilk test was used to assess normality and Levene's test was used to compare equality of variance among groups. Since cell estimates had dissimilar, non-normal distributions, non-parametric tests were used for initial group comparisons of leukocyte subtypes. The two-sample Kolmogorov-Smirov (KS) test was used to compare distribution of cell estimates when variances were unequal between groups and Mann-Whitney U test was used to compare mean ranks of cell estimates otherwise. Spearman's rank correlation was used to assess agreement between estimates based on RPC and CP deconvolution approaches. A threshold of 0.05 was used for p-values and p-values were adjusted for multiple comparisons using Holm's method (citation), unless otherwise specified.
To test our main hypothesis-that PTSD is associated with sex-specific shifts in leukocyte composition-initial sex-stratified analyses were conducted on all leukocyte subtypes using the non-parametric Mann-Whitney U test. For leukocyte subtypes determined to be significantly associated with lifetime PTSD in either sex based on initial Mann-Whitney U tests, a two-way analysis of covariance (ANCOVA; Type III) controlling for age, ancestry (based on DNAm ancestry PCs), and current smoking, was performed with post-hoc comparison of estimated marginal means to examine the effects of sex and lifetime PTSD on transformed cell estimates. Transformation for cell estimate was informed by conducting Tukey's Ladder of Powers to maximize normality based on the Shapiro-Wilks W statistic. Sex-stratified Kruskal-Wallis and post-hoc Dunn tests were conducted as additional follow-up to investigate possible differences in cell proportions by PTSD status (i.e., trauma-exposed controls, remitted PTSD, and current PTSD).
RESULTS
Demographic characteristics of sampled study participants from the DNHS and GTP
The demographic characteristics of study participants included in primary analyses investigating sex-specific associations between DNAm-based cell estimates and lifetime PTSD are presented in Table 1 . Of the 483 participants from the combined DNHS and GTP sample, 57.3% had a lifetime diagnosis of PTSD, 68.3% were female, and 38.7% were current smokers.
The study population was predominantly African-American (89.2%), based on self-reported race, and the median age was 48 years (IQR: 17.5; 37.5-55 years).
Comparison of leukocyte subtype estimates by sex and lifetime PTSD
Cell estimates were compared by sex and lifetime PTSD in each leukocyte subtype to establish overall differences. Significant overall sex differences were observed in the distributions of CD56 + natural killer (NK) cell (KS: D = 0.19, adj. p = 0.007) and CD8 + T cell (CD8T) proportions (KS: D = 0.16; adj. p = 0.04) in RPC estimates. Males showed greater variability than females for both NK and CD8T cells (male vs. female -IQRNK: 6.2% vs. 4.15%;
IQRCD8T: 9.5% vs. 6.2%), as well as higher median NK (5.5% vs. 4.4%) and lower median CD8T (9.0% vs. 9.7%) cell proportions ( Figure 1 ). Significant sex differences were also observed in the comparison set of CP estimates for the distributions of both NK (KS: D = 0.21, adj p = 0.001) and CD8T (KS: D = 0.25, adj p = 4.21×10 -5 ) cell estimates, with males again showing greater variability than females for both NK and CD8T cells (male vs. female -IQRNK: 7.3% vs. 5.2%; IQRCD8T: 6.4% vs. 5.1%), as well as higher median NK (5.0% vs. 2.9%) and lower median CD8T (11.6% vs. 13.5%) cell proportions ( Supplementary Figure 1) . No significant overall differences (i.e., in both sexes combined) were observed between lifetime PTSD cases and trauma-exposed controls in any leukocyte subtype, based on either RPC or CP estimate (Levene's test and Mann-Whitney U test).
Comparison of leukocyte subtype estimates by deconvolution approach
Good overall agreement was observed between RPC and CP estimates, as measured by Spearman's correlation (i.e., RPC-CP correlation), but CD8T cells showed much poorer agreement, ρs(481) = 0.83, relative to the other leukocyte subtypes, ρs(481) > 0.94. Since the main objective of this study was to investigate sex-specific shifts in leukocyte composition, comparison of RPC and CP estimates was stratified by sex ( Supplementary Figure 2 ). Sexstratified RPC-CP correlation revealed that the largest difference in RPC-CP correlation between sexes was also found in CD8T cells, |∆ρs| = 0.07, such that females showed poorer correlation, ρs(328) = 0.80, than males, ρs(151) = 0.87. For the other leukocyte subtypes, the difference in RPC-CP correlation between sexes (|∆ρs|), ranged from 0.01 to 0.03, with CD56 + natural killer (NK) cells having the second largest difference in correlation between sexes (female: ρs(328) = 0.93; male: ρs(151) = 0.96). In all leukocyte subtypes, except CD19 + B cells, females had lower correlation coefficients than males.
Elevated monocyte proportions are associated with lifetime PTSD in males, but not females
Sex-stratified Mann-Whitney U tests revealed a significant difference in monocyte proportions between PTSD cases and controls in males (Figures 2 and 3 ). Males with lifetime PTSD had higher median monocyte proportions than trauma-exposed controls, U = 2100, Z = -2.9, p = 0.004, adj. p = 0.026, r = 0.23. In contrast, no difference in monocyte estimates was found between groups in females, U = 13000, Z = -0.58, p = 0.6, adj. p = 1, r = 0.03. Lifetime PTSD-associated differences were not observed in any other leukocyte subtypes in either sex.
A two-way ANCOVA was conducted to investigate whether sex moderated the effects of lifetime PTSD on square root transformed monocyte estimates, while accounting for age, ancestry, and current smoking ( Table 2) . A significant interaction was found between sex and lifetime PTSD, F(1, 461) = 4.89, p = 0.027, ηp 2 = 0.011. Post-hoc comparison of estimated marginal means (EMMs) for lifetime PTSD by sex ( Figure 4 ; Table 3 ) showed a significant mean difference between lifetime PTSD cases and controls in males, ∆EMM = 0.26, SE = 0.08, t(461) = 3.32, p = 0.001, where mean monocyte estimates were higher in lifetime PTSD cases than controls. No significant mean difference was observed between PTSD cases and controls in females, ∆EMM = 0.05, SE = 0.05, t(461) = 0.89, p = 0.37, confirming findings from initial sexstratified analyses. Together, our results suggest that male PTSD cases have significantly elevated monocyte proportions compared to trauma-exposed controls and that this lifetime PTSD-associated shift is not observed in females.
Association between monocyte proportions and lifetime PTSD in males is independent of current PTSD status
To investigate whether participants with current PTSD exhibited a different monocyte profile from those with remitted PTSD, a sex-stratified Kruskal-Wallis test was conducted for PTSD status (i.e., trauma-exposed controls, remitted PTSD, and current PTSD; Figure 5 ). A significant difference in monocyte estimates was observed in males, H(2) = 8.2, p = 0.017, but not in females, H(2) = 1.1, p = 0.59, confirming findings from analyses for lifetime PTSD. The post-hoc Dunn test revealed significant differences between PTSD case groups and traumaexposed controls (current PTSD vs. controls: Z = 2.31, p = 0.021, adj. p = 0.042, r = 0.23; remitted PTSD vs controls: Z = 2.40, p = 0.016, adj. p = 0.049, r = 0.22), but no significant difference between current and remitted PTSD groups, Z = 0.18, p = 0.86, adj. p = 0.86, r = 0.02.
These findings suggest that the association between monocyte proportions and lifetime PTSD in males is independent of current PTSD state and may reflect long-standing changes associated with lifetime history of PTSD diagnosis.
CP-based estimates confirm male-specific association between lifetime PTSD and DNAmbased monocyte proportions
Comparative analyses using CP-based monocyte estimates confirmed our significant sexspecific finding between lifetime PTSD and monocyte proportions. As observed previously, males with lifetime PTSD had higher monocyte proportions than trauma-exposed controls, U = 2200, Z = -2.5, p = 0.01, r = 0.20, while no difference was found between PTSD cases and controls in females, U = 13000, Z = -0.15, p = 0.88, r = 0.008 ( Supplementary Figure 3) . A twoway ANCOVA on square root transformed CP-based estimates, accounting for age, ancestry, and current smoking ( Supplementary Table 1 ), showed a significant interaction between sex and lifetime PTSD, F(1,461) = 3.99, p = 0.046, ηp 2 = 0.009. Post-hoc comparison of EMMs by sex ( Supplementary Figure 4 ; Supplementary Table 2 ) confirmed a significant mean difference between lifetime PTSD cases and controls in males, with higher mean monocyte estimates in PTSD cases, ∆EMM = 0.24, SE = 0.09, t(461) = 2.85, p = 0.005. Again, no significant mean difference between PTSD cases and controls was found in females, ∆EMM = 0.04, SE = 0.06, t(461) = 0.63, p = 0.53. Smaller difference in EMM (∆EMM) and larger EMM standard error were observed in male CP estimates, compared to RPC estimates.
Finally, sex-stratified Kruskal-Wallis tests for PTSD status using CP-based monocyte estimates (Supplementary Figure 5 ) also suggested significant differences in males, H(2) = 6.5, p = 0.038, but not females, H(2) = 0.74, p = 0.69. While no difference was observed between current and remitted PTSD groups, Z = 0.24, p = 0.81, adj. p = 0.81, r = 0.03, in the post-hoc Dunn test, differences between PTSD cases and trauma-exposed controls showed smaller effect sizes and only nominal significance (current PTSD vs controls: Z = 2.11, p = 0.035, adj. p = 0.10, r = 0.21; remitted PTSD vs controls: Z = 2.10, p = 0.036, adj. p = 0.071, r = 0.19).
Overall, confirmation of primary findings in RPC-based monocyte estimates using CP estimates suggests that male-specific association of DNAm-based monocyte proportions with lifetime PTSD is consistent across deconvolution approaches. This is supported by lifetime PTSD analyses (i.e., Mann-Whitney U test, two-way ANCOVA, and post-hoc comparison of EMMs) and by comparison between current and remitted PTSD groups in males, which revealed no significant difference (post-hoc Dunn test). However, CP-based results consistently presented smaller effect sizes than RPC-based results across all analyses and follow-up comparisons between PTSD case groups and trauma-exposed controls did not reach significance after p-value adjustment in post-hoc Dunn test using CP monocyte estimates in males.
DISCUSSION
The primary goal of the present study was to test whether PTSD is associated with sexspecific shifts in leukocyte composition, detectable by DNAm-based estimates; in addition, we sought to implement two leukocyte composition estimation approaches to assess consistency of results across different deconvolution algorithms. We found that lifetime PTSD was associated with a small but significant elevation in monocyte proportions in males, but not females. No difference in monocyte proportions was observed between current and remitted PTSD cases in males, suggesting that this sex-specific peak shift reflects a long-standing trait of lifetime history of PTSD diagnosis, rather than current state of PTSD. Additionally, these findings were observed in both the primary robust partial correlation (RPC) and comparison constrained projection (CP)-based sets of cell estimates, which were derived using non-constrained vs.
constrained projection deconvolution algorithms, respectively. Overall, our main finding of elevated monocyte proportions in males, but not females with lifetime history of PTSD provides evidence for a sex-specific shift in peripheral blood leukocyte composition that is detectable in methylomic profiles and that reflects long-standing changes associated with PTSD diagnosis.
Methylomic profiles derived from peripheral blood offer a wealth of information on immune state that can be harnessed to detect shifts in leukocyte composition and epigenetic changes in regulation of immune processes. Methylomic profiles are particularly well-suited for investigating PTSD because DNAm encodes individual response to trauma and may play a key role in PTSD-associated immune dysregulation. Our study leveraged recent advances in reference-based deconvolution methods [62] [63] [64] to investigate sex-specific shifts in leukocyte composition associated with PTSD. Specifically, we implemented the EpiDISH algorithm 62 , which (i) employs DNase hypersensitive site (DHS) data of leukocyte subtypes to inform probe selection for their reference database and (ii) introduces robust partial correlation (RPC), a nonconstrained projection approach for reference-based deconvolution. Previous comparisons across deconvolution approaches suggest that RPC may, in general, be more robust than the established constrained projection (CP) approach 99 for realistic noise levels 62, 64 . Although our main finding in RPC-based monocyte estimates was confirmed using CP, effect sizes were consistently smaller and EMM standard errors were larger in CP-based monocyte estimates.
Additionally, follow-up comparisons between PTSD case groups and trauma-exposed controls in males did not reach significance after p-value adjustment in CP-based post-hoc Dunn test, despite significant results in other analyses of lifetime PTSD. Thus, RPC-based estimates were better able to resolve male-specific association of monocyte proportions with lifetime PTSD consistently across all conducted analyses compared to CP-based estimates and our results also favor use of RPC estimates for modeling leukocyte composition.
Comparison between RPC and CP estimates, based on the same EpiDISH reference database (of 330 leukocyte subtype discriminating CpG probes), further illustrates contexts where choice of deconvolution approach matters. Since RPC applies the non-negative and normalization constraints after deriving coefficients/proportion estimates and models by robust regression 62 , it is likely to demonstrate advantages over CP more clearly when the reference database does not adequately identify or account for major functional subsets of leukocyte subtypes (e.g., naïve vs. effector vs. memory CD8T cells). This may have been the case for CD8T cells, which exhibited much poorer correlation between RPC and CP estimates than other leukocyte subtypes and the largest difference in RPC-CP correlation between sexes. Probe selection for CD8T cells may be challenged by the active role of DNAm dynamics in regulating key processes that define CD8T cells 102 and sex differences in RPC-CP correlation may reflect the poorer fit to CD8T discriminating probes during CP estimation in females. Further investigation of baseline sex differences in cell-specific DNAm-levels, especially at leukocyte subtype-discriminating CpG probes (i.e., reference database), is warranted.
Comparison of leukocyte subtype estimates by sex revealed significant baseline sex differences in the distributions of NK cell and CD8T cell proportions, with males showing greater median NK and lower median CD8T cell proportions, using both RPC and CP based estimates. This finding is consistent with a previous study that reported sex differences in both leukocyte subtypes using estimates based on minfi's implementation of the Houseman approach 103 and with immunology literature that reported higher NK cell counts and proportions in males compared to females 104 . A recent study that modeled cell-specific methylation profiles also reported robust sex differences in CD56 + NK methylation patterns 105 , suggesting that this leukocyte subtype may be regulated by DNAm in a sex-specific manner. Additionally, DNAm dynamics have been found to drive effector functions in CD8T cells after stimulation 102, 106 .
Development of reference databases that resolve the six main leukocyte subtypes to consider proportions of subsets with shared lineage but different functionality/phenotype (e.g., naïve vs memory vs regulatory subtypes) may allow us to explore this hypothesis and would greatly enrich our understanding of immune activity.
Our main finding of elevated monocyte proportions in male lifetime PTSD cases is consistent with previously reported evidence. While not specifically in PTSD, a previous study of Gulf War Illness (GWI) in a predominantly male veteran cohort reported an association between GWI and increase in monocyte count 107 . Further prospective investigation in humans is needed to determine whether this male-specific difference in monocyte proportions reflects an increased susceptibility for developing PTSD or if it reflects an immunological shift in response to the precipitating trauma associated with PTSD psychopathology. Studies in male rodent models provide strong evidence for the latter and have been important for establishing the relationship between peripheral immune cells and the brain in the context of psychosocial stress and associated behavior. For example, repeated social defeat (RSD) was found to induce myelopoiesis and release inflammatory monocytes into circulation via sympathetic signaling, and this increased level of circulating peripheral monocytes was associated with recruitment of pro-inflammatory monocytes/macrophages to the brain and neuroinflammation 35, 108, 109 .
Macrophage recruitment to the brain was demonstrated to correspond with development, maintenance, and re-establishment of RSD-induced anxiety-like behavior, and blockade of this recruitment (via splenectomy or β-adrenergic receptor blockage) before RSD was found to prevent development of anxiety-like behavior 37, 38 . Additionally, a recent paper discerned that stress-induced anxiety-like behavior and social avoidance are dependent on an increase in IL-6 after stress exposure, which induces a primed transcriptional profile in monocytes recruited to the brain and propagates IL-1 mediated inflammation associated with anxiety-like behavior 110 .
These studies implicate peripheral monocytes in directly affecting PTSD-like behavior after stress exposure in males.
Unfortunately, all the aforementioned studies have been in males, so it is not clear to what extent these mechanistic insights pertain to females 111, 112 and recent investigations in rodent models suggest fundamental sex differences in neurobiological response to trauma exposure 17 .
Chronic PTSD-associated sex differences were noted in transcriptional regulation 113 and gene expression 114 of CD14 + monocytes isolated from peripheral blood, however no studies of PTSD have investigated sex differences in monocyte methylomic profiles. Given the inherent sex differences in innate immune response 115, 116 , as understood in the context of infection, injury, and treatment of inflammatory disorders, sexually dimorphic dynamics and effects may also exist in the context of neuroimmune response to stress/trauma exposure 111 . A study examining sex differences in regulation of inflammatory cell recruitment and cytokine synthesis found that ovarian hormones regulate phenotype, function, and numbers of macrophages, but not T lymphocytes, in females 117 . This fundamental sex difference may underlie more efficient recognition and elimination of infectious stimuli without recruitment of circulating neutrophils or excessive cytokine production in females, compared to males 117 , and may also have implications in the context of psychosocial stress exposure. Our observation of male-specific increase in monocyte proportions associated with lifetime PTSD may reflect fundamental sex differences in leukocyte trafficking, tissue distribution, and thus composition in blood, with implications for stress/trauma-induced neuroimmune alterations and behavior. It is also worth noting that the lack of difference between remitted and current PTSD (in male-specific elevation of monocyte proportions) may have a number of implications for PTSD pathophysiology, including adverse health consequences associated with PTSD across the life course in men, which may be distinct from PTSD-associated health trajectories in women [118] [119] [120] .
Although the current dataset combined two cohorts and known pregnancies were excluded from our study, sample size and unavailable phenotype data on pregnancy, timing of the menstrual cycle, hormonal birth control use, and health status, as well as gender-related variables, such as coping mechanisms, are all limitations of this study. A small study in adult females that matched PTSD participants and controls for phase of menstrual cycle agreed with our female-specific results and reported no difference between PTSD subjects and controls in percentage of any lymphocyte subsets or total numbers of leukocytes, neutrophils, lymphocytes, or monocytes 121 . However, this study was small (PTSD: n = 16; controls: n= 15) and healthy controls did not have a history of trauma exposure. Future studies that account for hormone levels and other fundamental physiological sex differences may help identify female-specific associations between PTSD and leukocyte composition and clarify if hormone-dependent processes influence leukocyte composition dynamics.
Overall, our literature-supported finding of male-specific elevation in monocyte proportions illustrates feasibility of using DNAm-based leukocyte composition estimates to probe immune profiles. DNAm-based monocyte proportions may be an informative metric to include as part of a diagnostic biomarker panel for PTSD in males, and future study in females, with consideration for hormonal status, may elucidate a female-specific panel as well.
Differential methylation markers discovered in sex-stratified EWAS, which account for these cell estimates as covariates, are other prime candidates to be included in such sex-specific biomarker panels. In fact, validation of recently published methods for determining cell-specific differential methylation profiles 122 may enable the next significant advance in extracting insights from methylomic profiles by contextualizing how differential methylation in specific leukocyte subtypes alter regulatory dynamics in the immune system. Ultimately, this work may help to shape future studies designed to determine whether sex-specific methylomic metrics of peripheral immune status can inform us about sex differences in neuroinflammation and corresponding behavior in response to trauma exposure.
CONCLUSION
By combining DNA methylation datasets from two civilian cohorts, the current study found a small but significant elevation in monocyte proportion associated with lifetime PTSD in males, but not females. This sex-specific shift in peripheral blood leukocyte composition reflects a long-standing trait of PTSD diagnosis, rather than current state of PTSD. While this finding was confirmed using two different cell estimation approaches (i.e., deconvolution algorithms), the recently developed non-constrained projection approach (RPC) appears better suited for modeling leukocyte composition. Methylome-based characterization of immune profiles holds special promise for the study of PTSD and continued development of reference databases and validation of methods will build on these recent improvements to enrich our understanding of sex-specific immune dysregulation associated with PTSD.
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Supplementary Figure 5:
Density plots for CP monocyte estimates comparing those with current PTSD, remitted PTSD, and trauma-exposed controls, stratified by sex. No significant difference is observed between current and remitted PTSD cases, which suggests that the significant peak shift in male PTSD cases is associated with long-standing PTSD trait, rather than current PTSD state. However, unlike RPC-based estimates, difference between PTSD case groups and trauma-exposed controls was only nominally significant in corresponding post-hoc Dunn test. No significant differences were observed in females. remitted PTSD, and trauma-exposed controls, stratified by sex. Distinguishing between current and remitted PTSD cases suggests that the significant peak shift in male PTSD cases is associated with long-standing PTSD trait, rather than current PTSD state. Corresponding post-hoc Dunn test revealed no significant difference between current and remitted PTSD cases and significant differences between PTSD case groups and trauma-exposed controls. Again, no significant differences were observed in females. Significance level of alpha = 0.05 was used for EMM comparisons. Results for pairwise comparison were averaged over levels for current smoking. Degree of freedom was 461 and male lifetime PTSD cases were significantly different from other groups.
